Specialist drug development consultancy

Deep expertise for better drug development

oncoKnow provides deep, specialist knowledge across drug development — with a particular focus on oncology and rare disease, and broad experience across other therapeutic areas.

Our expertise Work with us

20+

Years in drug development

50+

Projects delivered

Conventional & Advanced

Therapeutic modalities

EU & US

Regulatory expertise

What we do

Specialised knowledge where it matters most

With a primary focus on oncology and rare disease, and experience spanning broader therapeutic areas, we bring the depth and versatility that complex drug development programmes demand.

Translational Science as a System

Designing research backwards from patient, label and access, identifying translational gaps early across biology, clinic, CMC and regulation, and making preclinical data regulatory-fit, not just publication-fit.

End-to-End Drug Development

How the pipeline actually connects, spotting warning signs before FIH, PoC or MAA, aligning discovery, clinical, regulatory and CMC timelines, and knowing when not to advance a programme.

Clinical Development & Trial Strategy

Trials designed to answer both regulatory and value questions, balancing protocol trade-offs with real-life feasibility, with deep experience in early-phase rare disease and oncology and productive interfaces with CROs, sites and regulators.

Regulatory Thinking

Understanding how regulators think, not just what they ask for, briefing book narrative and strategy, knowing when to engage and when not to, across EMA, FDA and national authorities.

Science Communication

Tailoring data for regulators, investors, clinicians and boards, KOL advisory board design and moderation, and scientific storytelling that survives scrutiny.

Our approach

From insight to action — a partnership model

Deep discovery

We immerse ourselves in your compound, indication, and competitive landscape to understand what truly differentiates your programme.

Strategic design

Drawing on decades of oncology experience, we co-create development strategies that are scientifically rigorous and commercially aware.

Execution support

We stay alongside your team through implementation, providing expert guidance at every regulatory, clinical, and scientific milestone.

About oncoKnow

oncoKnow is founded by Nadina Grosios, PhD, MPH. Her driving ambition is to support teams working on innovative therapies and help bring those therapies as close and as accessible to patients as possible.

Over the past 20+ years she has worked across the full drug development pipeline reaching milestones from first-in-human through to Marketing Authorization. Her career spans laboratory leadership and translational science at Novartis and AstraZeneca, coordination of multidisciplinary academic research and health initiatives at the University of Leeds, NHS and Cancer Research UK, project leadership at uniQure, and consulting and clinical operations at SMS-oncology.

Since founding oncoKnow in 2018, she has helped multiple teams think translationally, decide wisely, and move therapies through real-world complexity without losing scientific integrity, or time.